Navigation Links
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Date:7/8/2008

part of a total treatment program for ADHD that may include other measures (e.g., psychological, educational, social) for patients with this syndrome.

Important Safety Information

The most common adverse events seen with Focalin XR were dyspepsia, decreased appetite, headache and anxiety in pediatric studies; and dry mouth, dyspepsia, feeling jittery, dizziness, headache and anxiety in adult studies.

Focalin XR is contraindicated in patients with marked anxiety, tension and agitation since the drug may aggravate these symptoms; in patients known to be hypersensitive to methylphenidate or other components of the product; in patients with glaucoma; in patients with motor tics or with a family history or diagnosis of Tourette's syndrome; and during or following treatment with monoamine oxidase inhibitors.

Stimulants should generally not be used in children, adolescents or adults with known serious structural cardiac abnormalities, cardiomyopathy, serious heart-rhythm abnormalities or other serious cardiac problems. Use with caution in treating patients with underlying medical conditions that might be compromised by increases in blood pressure or heart rate, such as those with pre-existing hypertension, heart failure, recent myocardial infarction or ventricular arrhythmia. Before initiating treatment, patients should have careful history and physical exam to assess for presence of cardiac disease.

Use with caution in psychosis or bipolar disorder. Discontinuation of treatment may be appropriate in the presence of treatment-emergent psychotic or manic symptoms. While aggressive behavior is often observed in children or adolescents with ADHD, patients beginning treatment should be monitored for the appearance of or worsening of aggressive behavior or hostility.

Suppression of growth has been reported with long-term use of stimulants. Stimulants should be used with caution in patients with a prior history of seizures or EEG abnorm
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
3. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Texas , July 28, 2015 ... Dermatology Devices Market by Type (Dermatology Treatment Devices, and ... Dermatoscopes, Microscopes]), by Application, by Geography - Analysis and ... expected to reach $11.88 billion by 2019, at a ... Browse through the TOC of Global Dermatology Devices Market ...
(Date:7/28/2015)... 28, 2015 Transparency Market Research (TMR) ... " Cancer Diagnostics Market - Global Industry Analysis, Size, ... . According to this report, the global cancer diagnostics market ... the forecast period of 2014 to 2020. In 2013, the ... is expected to be worth US$168,649.3 million by 2020.The increasing ...
(Date:7/28/2015)... Mass., July 28, 2015   Cynosure, Inc. ... and markets medical devices for aesthetic procedures and ... for the three months ended June 30, 2015. ... quarter of double-digit growth, as revenues increased 47 ... Cynosure Chief Executive Officer Michael Davin. "While our ...
Breaking Medicine Technology:Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13
... , Jan. 20 IDEXX Laboratories, Inc. (Nasdaq: IDXX ... financial results for Friday, January 29 , at approximately 7:00 ... 9:00 a.m. (eastern) on that day. , Individuals can ... the IDEXX Web site, www.idexx.com . An archived edition of the ...
... , , PLEASANTON, ... THOR ), a world leader in device-based mechanical circulatory ... today that it has received FDA approval of its PMA ... LVAS (Left Ventricular Assist System) for Destination Therapy (DT).   ...
Cached Medicine Technology:IDEXX Laboratories to Release 2009 Fourth Quarter and Full-Year Financial Results 2Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 2Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 3Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 4Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 5Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 6
(Date:7/28/2015)... ... July 28, 2015 , ... World ... Out, a new household invention that makes shelling eggs an exact science. , ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. “With a ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... the Lost and Found, a breakthrough technological invention. It is a wearable ... the consumer electronic industry reached a record high of $211.3 billion in 2014," ...
(Date:7/28/2015)... ... 2015 , ... The Denver Foundation and Blair-Caldwell African American ... a photographic and narrative exploration of African American giving, which runs August 1-31 ... Denver is one of only ten cities to host “The Soul of Philanthropy ...
(Date:7/28/2015)... NJ (PRWEB) , ... July 28, 2015 , ... Morristown ... in New Jersey, and one of the first five hospitals in the nation, to ... in three patients on July 23, and all are in good condition. , The ...
(Date:7/28/2015)... ... July 28, 2015 , ... Autism is ... 68 children currently affected with the disorder. For these families, identifying and paying ... recovery is extremely daunting. That’s where Talk About Curing Autism (TACA), a national ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2
... April 4. Given an awaiting crowd of 80,000 and the ... team can feel cheerful about here are a spruced up// ... one-day cricket match between England and India takes place at ... a traditional Kerala welcome when they arrived from Goa Tuesday ...
... has been found that if there is Intrahepatic cholestasis during ... ,This case control study was performed in ... Intrahepatic cholestasis of pregnancy (ICP) is an itchy skin condition ... ,The study is published in the April 2006 issue of ...
... edition Journal of the American Dietetic Association, introducing soymilk ... children// who select a calcium-rich beverage in the lunch ... fat consumed from calcium-rich beverages. ,A four ... schools in Florida. The results were that almost a ...
... found that immune system gets boosted in people who are ... the risk of brain cancer. // ,"It appears ... Michael Scheurer, the study's lead author. "They seem to produce ... active and working to prevent cancer from beginning to develop.", ...
... in the brain, and quite a tongue twister called the ... // It seems as though there is more to the ... Women are from Venus! ,Researchers have discovered that ... behaves differently in males and females, while at rest and ...
... discovered the epinephrine QT stress test that can predict the long ... ,The Long QT syndrome is a rare yet almost fatal, heart ... every 3000 people in the United States. Its name comes from ... such people with the disease. , If untreated, 50% ...
Cached Medicine News:Health News:Intrahepatic cholestasis during pregnancy predisposes to later liver disease 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: